#Best eBus company in India
Text
Top EV Stocks in India... (not Tata Motors)
Top EV Stocks in India… (not Tata Motors)
Get out of all petrol two-wheeler stocks… they are heading for a disruption… and they are not ready for that at all. What they have on offer is half the range of its competition yet priced 40% more than its competition.
Share Price movement over last 5 yrs of Olectra Greentech, JBM Auto, Tata Motors & Ashok Leyland
Well the game just got started… there is going to be more… like Oppo, Vivo,…
View On WordPress
#Best eBus company in India#best ebus maker in India#best green energy stocks#best green energy stocks 2022#best renewable energy stocks#best solar energy stocks in india#best stock for ev revolution#clean energy stocks#ev battery stocks#ev car share#ev manufacturing companies#ev space stocks#ev stocks india#ev stocks list#green energy penny stocks#green energy stocks#green energy stocks in india#green energy stocks to buy in#renewable energy penny stocks#renewable energy stocks#renewable energy stocks in india#solar energy penny stocks#solar energy stock in india#solar energy stocks#stocks to benefit from ev#top EV company in India#top green energy stocks
0 notes
Text
Global Endobronchial Ultrasound Biopsy Market to Witness Excellent Long-Term Growth Outlook 2019
Endobronchial ultrasound (EBUS) is a minimally invasive but highly effective procedure used to diagnose lung cancer, infections, and other diseases causing enlarged lymph nodes in the chest.
In 2018, the global Endobronchial Ultrasound Biopsy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Endobronchial Ultrasound Biopsy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Endobronchial Ultrasound Biopsy development in United States, Europe and China.
Get Free Sample PDF Of The Report: https://www.researchmoz.us/enquiry.php?type=S&repid=2374402
The key players covered in this study
Boston Scientific
Medtronic
MEDI-GLOBE
CONMED
Olympus
Veran Medical
CLINODEVICE
Cook Medical
Market segment by Type, the product can be split into
Biopsy Forceps
Cytology Brushes
Transbronchial Aspirational Needles
Spray Catheters, Biopsy Needles
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Cancer Specialty Clinics
Diagnostic Centers
Make an Enquiry at: https://www.researchmoz.us/enquiry.php?type=E&repid=2374402
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Endobronchial Ultrasound Biopsy status, future forecast, growth opportunity, key market and key players.
To present the Endobronchial Ultrasound Biopsy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Endobronchial Ultrasound Biopsy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Website: https://www.researchmoz.us
Email: [email protected]
Blog: https://blogreportstudy.blogspot.com/
Follow us on LinkedIn @ https://www.linkedin.com/showcase/13221461
0 notes
Text
Endobronchial Ultrasound Biopsy Market Research Report: Forecast up to 2025
Technological advancements in last couple of decades have made diagnosis of lung cancer easy using endobronchial ultrasound (EBUS) biopsy technique. Endobronchial ultrasound is minimally invasive technique that uses ultrasound along with bronchoscope to examine airway walls and structure adjacent to it. Ultrasound technology used in this procedure allows examination of multilayer tracheobronchial wall structure better than any other imaging technique. Endobronchial ultrasound biopsy has become best alternative to other traditional procedures such as fluoroscopic guided biopsy, fiberoptic bronchoscope, mediastinoscopy or thoracotomy. Using these traditional limits the view of bronchoscopist to bronchial mucosa and lumen, whereas EBUS has widen the vision beyond tracheobronchial wall. Endobronchial ultrasound biopsy is performed on outpatient basis under local anesthesia using thin needle aspiration. Endobronchial ultrasound guided tracheobronchial needle aspiration method has enabled real-time aspiration of lesions near to trachea and large bronchi.
The use of this technique is rapidly gaining popularity due to accumulation of large amount of data related to safety and effectiveness of the technique. As per European Respiratory Journal, EBUS presents positive likelihood ratio of 26.8 and negative likelihood ratio of 0.28. According to American College of Chest Physicians, EBUS is recommended as first procedure to before surgical staging for lung cancer diagnosis in the U.S.
The global market endobronchial ultrasound biopsy is expected to be driven by incidence of lung cancer all over the world. According to Cancer Research U.K., 46,403 new lung cancer cases were diagnosed in U.K. in 2014, which accounted for 13% of all new cancer cases. According to American Lung Association, Lung cancer is the most common cancer across the globe accounting for 1.8 Mn new cases worldwide in 2012. And is most prevalent in elderly person. 83% of patients living with lung cancer are 60 years-old or above. Growing geriatric population thus can be a factor contributing to growth of endobronchial ultrasound biopsy market over the forecast period. However, the biggest restraint for growth of endobronchial ultrasound biopsy market is unawareness about the technique. Despite the technique is being used for last two decade in matured markets, developing countries such as India and China have recently introduced to this technique.
One of the main applications of endobronchial ultrasound biopsy is in staging of cancer. Introduction of this technique has made dramatic changes in treatment planning for lung cancer. In 2016, American Medical Association created three new CPT codes for endobronchial ultrasound biopsy procedure. Thus all the services using EBUS including aspiration biopsy are reimbursed by Medicare
View Report-
http://www.transparencymarketresearch.com/endobronchial-ultrasound-biopsy-market.html
The global market endobronchial ultrasound biopsy is segmented on basis of procedure type, end user and geography:
Segmentation by Procedure Type
Radial Endobronchial Ultrasound Biopsy
Linear Endobronchial Ultrasound Biopsy
Segmentation by End User
Hospitals
Ambulatory Surgical Centers
Cancer Specialty Clinics
Hospitals end user segment is expected to be dominant in global endobronchial ultrasound biopsy market due to high patient population EBUS procedure is generally provided on outpatient or day case basis.
Regionally, global endobronchial ultrasound biopsy market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America clearly dominates the global market endobronchial ultrasound biopsy due to high prevalence and growing adoption of technique by physicians and patients. Europe is expected to be the second largest market endobronchial ultrasound biopsy. Asia pacific endobronchial ultrasound biopsy market is expected to witness steady growth over the forecast period of 2017–2025, primarily due to delayed introduction of EBUS technique in the region and limited availability of qualified resources to perform the procedure.
Olympus Europa SE & CO. KG is the major player that provides endobronchial ultrasound biopsy systems globally. Some of the popular brands of video bronchoscopes provided by the company include BF-Q180, BF-P180, BF-3C160, etc.
Request a brochure of this report to know what opportunities will emerge in the rapidly evolving Endobronchial Ultrasound Biopsy Market during 2017- 2025
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=25982
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com
0 notes
Text
Endobronchial Ultrasound Biopsy Market Research Report: Forecast up to 2025
Technological advancements in last couple of decades have made diagnosis of lung cancer easy using endobronchial ultrasound (EBUS) biopsy technique. Endobronchial ultrasound is minimally invasive technique that uses ultrasound along with bronchoscope to examine airway walls and structure adjacent to it. Ultrasound technology used in this procedure allows examination of multilayer tracheobronchial wall structure better than any other imaging technique. Endobronchial ultrasound biopsy has become best alternative to other traditional procedures such as fluoroscopic guided biopsy, fiberoptic bronchoscope, mediastinoscopy or thoracotomy. Using these traditional limits the view of bronchoscopist to bronchial mucosa and lumen, whereas EBUS has widen the vision beyond tracheobronchial wall. Endobronchial ultrasound biopsy is performed on outpatient basis under local anesthesia using thin needle aspiration. Endobronchial ultrasound guided tracheobronchial needle aspiration method has enabled real-time aspiration of lesions near to trachea and large bronchi.
The use of this technique is rapidly gaining popularity due to accumulation of large amount of data related to safety and effectiveness of the technique. As per European Respiratory Journal, EBUS presents positive likelihood ratio of 26.8 and negative likelihood ratio of 0.28. According to American College of Chest Physicians, EBUS is recommended as first procedure to before surgical staging for lung cancer diagnosis in the U.S.
The global market endobronchial ultrasound biopsy is expected to be driven by incidence of lung cancer all over the world. According to Cancer Research U.K., 46,403 new lung cancer cases were diagnosed in U.K. in 2014, which accounted for 13% of all new cancer cases. According to American Lung Association, Lung cancer is the most common cancer across the globe accounting for 1.8 Mn new cases worldwide in 2012. And is most prevalent in elderly person. 83% of patients living with lung cancer are 60 years-old or above. Growing geriatric population thus can be a factor contributing to growth of endobronchial ultrasound biopsy market over the forecast period. However, the biggest restraint for growth of endobronchial ultrasound biopsy market is unawareness about the technique. Despite the technique is being used for last two decade in matured markets, developing countries such as India and China have recently introduced to this technique.
One of the main applications of endobronchial ultrasound biopsy is in staging of cancer. Introduction of this technique has made dramatic changes in treatment planning for lung cancer. In 2016, American Medical Association created three new CPT codes for endobronchial ultrasound biopsy procedure. Thus all the services using EBUS including aspiration biopsy are reimbursed by Medicare
View Report-
http://www.transparencymarketresearch.com/endobronchial-ultrasound-biopsy-market.html
The global market endobronchial ultrasound biopsy is segmented on basis of procedure type, end user and geography:
Segmentation by Procedure Type
Radial Endobronchial Ultrasound Biopsy
Linear Endobronchial Ultrasound Biopsy
Segmentation by End User
Hospitals
Ambulatory Surgical Centers
Cancer Specialty Clinics
Hospitals end user segment is expected to be dominant in global endobronchial ultrasound biopsy market due to high patient population EBUS procedure is generally provided on outpatient or day case basis.
Regionally, global endobronchial ultrasound biopsy market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America clearly dominates the global market endobronchial ultrasound biopsy due to high prevalence and growing adoption of technique by physicians and patients. Europe is expected to be the second largest market endobronchial ultrasound biopsy. Asia pacific endobronchial ultrasound biopsy market is expected to witness steady growth over the forecast period of 2017–2025, primarily due to delayed introduction of EBUS technique in the region and limited availability of qualified resources to perform the procedure.
Olympus Europa SE & CO. KG is the major player that provides endobronchial ultrasound biopsy systems globally. Some of the popular brands of video bronchoscopes provided by the company include BF-Q180, BF-P180, BF-3C160, etc.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Request a brochure of this report to know what opportunities will emerge in the rapidly evolving Endobronchial Ultrasound Biopsy Market during 2017- 2025
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=25982
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com
0 notes
Last Seen Blogs
ode-to-berlermo
hola chiques
mycutiekye24-blog
Untitled
donnasteppe
Donna Steppe, Realtor
gyerekzene
Gyerek playlist
bloodiedbeloveds
local amrev changelings